As with IL-1β secretion, COVID-19 PMNs were less responsive than HC PMNs to nigericin- and LPS-mediated LDH (Fig 5F) and IL-8 (Fig 5G) release, respectively. The gene discussed is IL1B; the disease is COVID-19.